US6770662B2 - Benzoylpyridine derivative or its salt, fungicide containing it as an active ingredient, its production process and intermediate for producing it - Google Patents

Benzoylpyridine derivative or its salt, fungicide containing it as an active ingredient, its production process and intermediate for producing it Download PDF

Info

Publication number
US6770662B2
US6770662B2 US10/312,040 US31204002A US6770662B2 US 6770662 B2 US6770662 B2 US 6770662B2 US 31204002 A US31204002 A US 31204002A US 6770662 B2 US6770662 B2 US 6770662B2
Authority
US
United States
Prior art keywords
group
meo
optionally substituted
formula
alkoxy group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US10/312,040
Other languages
English (en)
Other versions
US20030216444A1 (en
Inventor
Hisaya Nishide
Munekazu Ogawa
Hidemasa Kominami
Koji Higuchi
Akihiro Nishimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ishihara Sangyo Kaisha Ltd
Original Assignee
Ishihara Sangyo Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27343965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US6770662(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ishihara Sangyo Kaisha Ltd filed Critical Ishihara Sangyo Kaisha Ltd
Assigned to ISHIHARA SANGYO KAISHA, LTD. reassignment ISHIHARA SANGYO KAISHA, LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: OGAWA, MUNEKAZU, HIGUCHI, KOJI, KOMINAMI, HIDEMASA, NISHIDE, HISAYA, NISHIMURA, AKIHIRO
Publication of US20030216444A1 publication Critical patent/US20030216444A1/en
Application granted granted Critical
Publication of US6770662B2 publication Critical patent/US6770662B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/02Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom
    • A01N47/06Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom containing —O—CO—O— groups; Thio analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • C07D213/6432-Phenoxypyridines; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles

Definitions

  • the present invention relates to a novel benzoylpyridine derivative or its salt, a fungicide containing it as an active ingredient, its production process and an intermediate for producing it.
  • Benzoylpyridine derivatives which are analogous to the compounds of the present invention may be compounds as disclosed in e.g. WO99/41237, WO99/38845, WO96/17829, JP-A-7-309837 and JP-A-2-275858. However, they are different from the compounds of the present invention. Further, the purposes of use of these compounds are different from those of the compounds of the present invention.
  • the present inventors have conducted extensive studies to overcome the above problems and as a result, have found that use of the compound represented by the formula (I) as an active ingredient presents excellent preventive effect and curative effect against various plant diseases, particularly powdery mildew of barley, vegetables, fruits and flowering plants, and the present invention has been accomplished.
  • the present invention relates to a benzoylpyridine derivative represented by the formula (I) or its salt:
  • X is a halogen atom, a nitro group, a substitutable alkoxy group, a substitutable aryloxy group, a substitutable cycloalkoxy group, a hydroxyl group, a substitutable hydrocarbon group, a substitutable alkylthio group, a cyano group, a carboxyl group which may be esterified or amidated, or a substitutable amino group;
  • n is 1, 2, 3 or 4;
  • R 1 is a substitutable alkyl group;
  • R 2 is a substitutable alkyl group, a substitutable alkoxy group, a substitutable aryloxy group, a substitutable cycloalkoxy group or a hydroxyl group; and
  • m is 1, 2, 3 or 4, provided that when m is at least 2, R 2 may contain an oxygen atom to form a condensed ring (excluding a case where the pyridine ring is substituted by a benzoyl group at the 2-position; the pyridine ring is
  • the halogen atom represented by X may, for example, be fluorine, chlorine, bromine or iodine, and preferably fluorine, chlorine or bromine, may, for example, be used.
  • the alkoxy moiety in the substitutable alkoxy group represented by each of X and R 2 may, for example, be a C 1-6 alkoxy (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy or t-butoxy), and preferably it may, for example, be a C 1-4 alkoxy (such as methoxy or ethoxy)
  • the secondary substituent of the substitutable alkoxy group may be from one to five substituents which are the same or different, selected from the group consisting of an aryl, an aryloxy, hydroxyl, nitro, nitroxy, a halogen (such as fluorine, chlorine, bromine or iodine), a haloalkoxy (such as a C 1-4 haloalkoxy such as CF 3 O or HCF 2 O), a cycloalkyl, amino, an alkylthio and cyano.
  • substitutable alkoxy groups preferred is an alkoxy
  • aryl moiety in the substitutable aryloxy group represented by X a condensation type polycyclic group such as naphthyl as well as phenyl may be mentioned, and preferred is phenyl.
  • the secondary substituent of the substitutable aryloxy group may, for example, be a halogen, an alkyl, an alkoxy or hydroxyl. Of these substitutable aryloxy groups, most preferred is a phenoxy group.
  • the cycloalkyl moiety in the substitutable cycloalkoxy group represented by X is usually one having a carbon number of from 3 to 10, and a monocyclic group such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl or cyclooctyl, as well as a condensation type polycyclic group, may, for example, be mentioned. However, preferred is a monocyclic group.
  • the secondary substituent of the substitutable cycloalkoxy group may, for example, be a halogen, an alkyl, an alkoxy or hydroxyl. Of these substitutable cycloalkoxy groups, most preferred is a cyclohexyloxy group.
  • the hydrocarbon moiety in the substitutable hydrocarbon group represented by X may, for example, be a C 1-6 alkyl group (such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl or t-butyl), a C 2-6 alkenyl (such as vinyl, allyl, isopropenyl or 3-methyl-2-butenyl), a C 2-6 alkynyl (such as ethynyl, 1-propynyl or 2-propynyl), a C 3-6 cycloalkyl (such as cyclopropyl, cyclopentyl or cyclohexyl), or a C 6-10 aryl.
  • a C 1-6 alkyl group such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl or t-butyl
  • a C 2-6 alkenyl such as vinyl, allyl, iso
  • the secondary substituent of the substitutable hydrocarbon group may be from one to five substituents which are the same or different, selected from the group consisting of an aryl, an aryloxy, hydroxyl, nitro, nitroxy, a halogen (such as fluorine, chlorine, bromine or iodine), a haloalkoxy (such as a C 1-4 haloalkoxy such as CF 3 O or HCF 2 O), a cycloalkyl, amino, an alkylthio and cyano.
  • substitutable hydrocarbon groups preferred is a substitutable alkyl group, and particularly preferred is an alkyl group. Further, a C 1-4 alkyl group is most preferred among alkyl groups.
  • the alkylthio moiety in the substitutable alkylthio group represented by X may, for example, be a C 1-6 alkylthio (such as methylthio, ethylthio, propylthio, isopropylthio, butylthio, isobutylthio or t-butylthio), and preferably a C 1-4 alkylthio (such as methylthio or ethylthio) may, for example, be mentioned.
  • a C 1-4 alkylthio such as methylthio or ethylthio
  • alkylthio groups which may be substituted preferred is an alkylthio group, particularly preferred is a C 1-4 alkylthio group.
  • the secondary substituent of the substitutable alkylthio group may be from one to five substituents which are the same or different, selected from the group consisting of an aryl, an aryloxy, hydroxyl, nitro, nitroxy, a halogen (such as fluorine, chlorine, bromine or iodine), a haloalkoxy (such as a C 1-4 haloalkoxy such as CF 3 O or HCF 2 O) and cyano.
  • a halogen such as fluorine, chlorine, bromine or iodine
  • a haloalkoxy such as a C 1-4 haloalkoxy such as CF 3 O or HCF 2 O
  • the carboxyl group which may be esterified or amidated, represented by X may, for example, be a carboxyl group which may be esterified such as a C 1-6 alkoxycarbonyl group (such as a methoxycarbonyl group, an ethoxycarbonyl group, a propoxycarbonyl group, an isopropoxycarbonyl group, a butoxycarbonyl group, an isobutoxycarbonyl group or t-butoxycarbonyl group), a nitroxy C 1-4 alkoxyaminocarbonyl group (such as 2-nitroxyethoxycarbonyl group or a 3-nitroxypropoxycarbonyl group), a phenyl C 1-4 alkoxycarbonyl group (such as a benzyloxycarbonyl group or a phenethyloxycarbonyl group); or a carboxyl group which may be amidated such as a carbamoyl group, a C 1-6 monoalkylaminocarbonyl group (such
  • the substitutable amino group represented by X may, for example, be an amino group or an alkylamino group such as a monoalkylamino group or a dialkylamino group.
  • the alkyl moiety in the alkylamino group is preferably a C 1-4 alkyl.
  • the secondary substituent of the substitutable amino group may be from one to five substituents which are the same or different, selected from the group consisting of an aryl, an aryloxy, hydroxyl, nitro, nitroxy, a halogen (such as fluorine, chlorine, bromine or iodine), a haloalkoxy (such as a C 1-4 haloalkoxy group such as CF 3 O or HCF 2 O), a cycloalkyl, amino, an alkylthio and cyano.
  • substituents which are the same or different, selected from the group consisting of an aryl, an aryloxy, hydroxyl, nitro, nitroxy, a halogen (such as fluorine, chlorine, bromine or iodine), a haloalkoxy (such as a C 1-4 haloalkoxy group such as CF 3 O or HCF 2 O), a cycloalkyl, amino, an alkylthio and
  • the alkyl moiety in the substitutable alkyl group represented by each of R 1 and R 2 is preferably a C 1-6 alkyl (such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl or t-butyl), and among them, preferred is a C 1-4 alkyl.
  • the secondary substituent of the substitutable alkyl group may be from one to five substituents which are the same or different, selected from the group consisting of an aryl, an aryloxy, hydroxyl, nitro, nitroxy, a halogen (such as fluorine, chlorine, bromine or iodine), a haloalkoxy (such as a C 1-4 haloalkoxy such as CF 3 O or HCF 2 O), a cycloalkyl, amino, an alkylthio and cyano.
  • substitutable alkyl groups preferred is an alkyl group which is not substituted, and particularly preferred is a C 1-4 alkyl group. Among them, most preferred is a methyl group.
  • the alkoxy moiety in the substitutable alkoxy group represented by R 2 is preferably a C 1-6 (alkoxy such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy or t-butoxy), and among them, preferred is a C 1-4 alkoxy.
  • the secondary substituent of the substitutable alkoxy group may be from one to five substituents which are the same or different, selected from the group consisting of an aryl group, an aryloxy group, a hydroxyl group, a nitro group, a nitroxy group, a halogen atom (such as fluorine, chlorine, bromine or iodine), a haloalkoxy group (such as a C 1-4 haloalkoxy group such as CF 3 O or HCF 2 O), a cycloalkyl group, an amino group, an alkylthio group and a cyano group.
  • substitutable alkoxy groups most preferred is an alkoxy group which is not substituted.
  • aryl moiety in the substitutable aryloxy group represented by R 2 a condensation type polycyclic group such as naphthyl, as well as phenyl, may be mentioned, and preferred is phenyl.
  • the secondary substituent of the substitutable aryloxy group may, for example, be a halogen atom, an alkyl group, an alkoxy group or a hydroxyl group. Of these substitutable aryloxy groups, most preferred is a phenoxy group which is not substituted.
  • the cycloalkyl moiety in the substitutable cycloalkoxy group represented by R 2 is usually one having a carbon number of from 3 to 10, and a monocyclic group such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl or cyclooctyl, as well as a condensation type polycyclic group, may, for example, be mentioned, however, preferred is a monocyclic group.
  • the secondary substituent of the substitutable cycloalkoxy group may, for example, be a halogen, an alkyl, an alkoxy or hydroxyl. Of these substitutable cycloalkoxy groups, most preferred is a cyclohexyloxy group which is not substituted.
  • the aryl moiety, the cycloalkyl group and the alkylthio group in the secondary substituent of the substituent represented by X, R 1 and R 2 are as defined for the substituents represented by X, R 1 , R 2 and R 3 .
  • the compound represented by the formula (I) may form a salt together with an acid substance, and it can form, for example, an inorganic salt such as a hydrochloride, a hydrobromate, a phosphate, a sulfate or a nitrate, or an organic salt such as an acetate, a benzoate, a p-toluenesulfonate, a methanesulfonate or a propanesulfonate.
  • an inorganic salt such as a hydrochloride, a hydrobromate, a phosphate, a sulfate or a nitrate
  • organic salt such as an acetate, a benzoate, a p-toluenesulfonate, a methanesulfonate or a propanesulfonate.
  • R 2′ , R 2′′ and R 2′′′ are as defined for the above R 2
  • X 1 , X 2 , X 3 and X 4 are as defined for the above X.
  • R 2′ is a substitutable alkyl group, a substitutable alkoxy group, a substitutable aryloxy group, a substitutable cycloalkoxy group or a hydroxyl group
  • p is 1, 2 or 3
  • R 2 ′′ is a substitutable alkoxy group or a hydroxyl group, provided that at least two of R 2′ and R 2′′ may contain an oxygen atom to form a condensed ring (excluding a case where the pyridine ring is substituted by a benzoyl group at the 2-position; the pyridine ring is substituted by an alkoxy group, a hydroxyl group or a benzyloxy group at the 3-position; and n is 1, p is 1).
  • X is a halogen atom, a nitro group, a substitutable alkoxy group, a substitutable aryloxy group, a substitutable cycloalkoxy group, a substitutable hydrocarbon group, a substitutable alkylthio group, a cyano group, a carboxyl group which may be esterified or amidated, or a substitutable amino group;
  • n is 1, 2 , 3 or 4;
  • R 1 is an alkyl group;
  • R 2′ is a substitutable alkyl group, a substitutable alkoxy group, a substitutable aryloxy group or a substitutable cycloalkoxy group;
  • p is 1, 2 or 3; and each of R 2′′ and R 2′′′ is a substitutable alkoxy group.
  • X is a halogen atom, a nitro group, a substitutable alkoxy group, a substitutable cycloalkoxy group, an alkyl group, a substitutable alkylthio group or a substitutable amino group; n is 1, 2, 3, or 4; R 1 is an alkyl group; R 2′ is a substitutable alkyl group, a substitutable alkoxy group, a substitutable aryloxy group or a substitutable cycloalkoxy group; p is 1, 2 or 3; each of R 2′′ and R 2′′′ is a substitutable alkoxy group (excluding a case where the pyridine ring is substituted by a benzoyl group at the 3-position, and the pyridine ring has a CF 3 group at at least one of the 2,6-positions).
  • X is a halogen atom, a substitutable alkoxy group, an alkyl group, a CF 3 group or an alkylthio group
  • n is 1, 2, 3 or 4
  • R 1 is an alkyl group
  • R 2 is a substitutable alkyl group, a substitutable alkoxy group or a substitutable cycloalkoxy group
  • p is 1, 2 or 3
  • each of R 2′′ and R 2′′′ is a substitutable alkoxy group.
  • X is a halogen atom, a substitutable alkoxy group, an alkyl group, a CF 3 group or an alkylthio group
  • n is 1, 2, 3, or 4
  • R 1 is an alkyl group
  • R 2′ is a substitutable alkyl group, a substitutable aryloxy group or a substitutable cycloalkoxy group
  • p is 1, 2 or 3
  • each of R 2′′ and R 2′′′ is a substitutable alkoxy group (excluding a case where the pyridine ring is substituted by a benzoyl group at the 3-position, and the pyridine ring has a CF 3 group at at least one of the 2,6-positions).
  • X is a halogen atom, an alkoxy group, an alkyl group, a CF 3 group or an alkylthio group; n is 1, 2 or 3; R 1 is an alkyl group; R 2′ is an alkoxy group; p is 1, 2 or 3; and each of R 2′′ and R 2′′′ is an alkoxy group.
  • X is a halogen atom, an alkoxy group, an alkyl group, a CF 3 group or an alkylthio group; n is 1, 2 or 3; R 1 is an alkyl group; R 2′ is an alkoxy group; p is 1, 2 or 3; and each of R 2′′ and R 2′′′ is an alkoxy group (excluding a case where the pyridine ring is substituted by a benzoyl group at the 3-position, and the pyridine ring has a CF 3 group at at least one of the 2, 6-positions).
  • B is —CX 4 ⁇ when A is —N ⁇ ; B is —N ⁇ when A is —CH ⁇ ; each of X 1 and X 2 which are independent of each other, is a halogen atom, an alkoxy group, an alkyl group, a CF 3 group or an alkylthio group;
  • X 3 is a hydrogen atom, a halogen atom, an alkoxy group, an alkyl group, a CF 3 group or an alkylthio group;
  • X 4 is a hydrogen atom, a halogen atom, an alkoxy group, an alkyl group, a CF 3 group or an alkylthio group;
  • R 1 is an alkyl group;
  • R 2′ is an alkoxy group;
  • B is —CX 4 ⁇ when A is —N ⁇ ; B is —N ⁇ when A is —CH ⁇ ; each of X 1 and X 2 which are independent of each other, is a halogen atom, an alkoxy group, an alkyl group, a CF 3 group or an alkylthio group;
  • X 3 is a hydrogen atom, a halogen atom, an alkoxy group, an alkyl group, a CF 3 group or an alkylthio group;
  • X 4 is a hydrogen atom, a halogen atom, an alkoxy group, an alkyl group, a CF 3 group or an alkylthio group;
  • R 1 is an alkyl group;
  • R 2′ is an alkoxy group;
  • the compound represented by the formula (I) or its salt may be produced in accordance with a known production process of an analogous compound (such as a process as disclosed in WO96/17829).
  • an analogous compound such as a process as disclosed in WO96/17829.
  • Processes 1 to 3 as shown in the following schemes may be mentioned.
  • X, R 1 , R 2 , n and m in the formulae are as defined above.
  • One of the substituents represented by M 1 in the formula (II) and M 2 in the formula (III) is a cyano group, and the other is a metal atom or a composite salt thereof;
  • the substituent represented by W in the formula (V) is a halogen atom or a trifluoromethane sulfonyloxy group;
  • one of the substituents represented by M 3 in the formula (VI) and M 4 in the formula (VII) is a formyl group, and the other is a metal atom or a composite salt thereof.
  • X, R 1 , R 2 , n and m are as defined above, and Z is a metal atom or a composite salt thereof, and hydrolyzing it.
  • the metal atom represented by each of M 1 and M 2 in the formulae (II) and (III) may, for example, be a typical metal atom such as lithium, magnesium, zinc or copper; or a transition metal atom such as palladium or ruthenium. Further, a composite salt of a metal atom may be used instead of a metal atom.
  • the compound of the formula (II) wherein M 1 is a cyano group and the compound of the formula (III) wherein M 2 is a cyano group may be produced in accordance with a known process such as a process as disclosed in Journal of the Chemical Society, Perkin transactions 1 pages 2323-2326, 1999.
  • the condensation reaction to produce an imine compound is carried out in the presence of a proper solvent (such as an inert solvent such as tetrahydrofuran, diethyl ether, dimethoxyethane, hexane, benzene, toluene or methylene chloride, or a mixed solvent thereof) at a reaction temperature of from ⁇ 100 to 70° C., preferably from ⁇ 80 to 30° C.
  • a proper solvent such as an inert solvent such as tetrahydrofuran, diethyl ether, dimethoxyethane, hexane, benzene, toluene or methylene chloride, or a mixed solvent thereof
  • This reaction is carried out preferably in an inert gas atmosphere of e.g nitrogen or argon.
  • the imine compound produced by the condensation reaction is hydrolyzed by a known procedure and converted into the compound represented by the formula (I).
  • the hydrolysis reaction may be carried out in the presence of e.g. water, an alcohol or a mixture thereof.
  • Process 1 the condensation reaction and the hydrolysis reaction are usually carried out continuously, and no imine compound is isolated. Further, to obtain the compound represented by the formula (I) with a high yield, it is preferred to carry out the hydrolysis reaction after the condensation reaction is completely conducted.
  • the reaction to produce the compound represented by the formula (IX) at the first half stage of Process 2 is carried out usually in the presence of a base preferably in a solvent.
  • the base to be used for the reaction may, for example, be lithium hydride, sodium hydride, sodium methoxide, sodium ethoxide or potassium tert-butoxide.
  • the solvent may, for example, be tetrahydrofuran, diethyl ether, benzene, toluene, methylene chloride, chloroform or DMF, or a mixed solvent thereof.
  • This reaction is carried out preferably at a reaction temperature of from 0 to 100° C. Further, it is carried out preferably in an inert gas atmosphere of e.g. nitrogen or argon. Further, sodium benzenesulfinate or sodium p-toluenesulfinate may be added as the case requires to accelerate the reaction.
  • the oxidative decyanogenation reaction at the last half stage in Process 2 is carried out in the presence of a base.
  • the base may, for example, be sodium hydride, potassium hydride, sodium carbonate or potassium carbonate.
  • a phase-transfer catalyst such as benzyl triethylammonium chloride or tetrabutylammonium hydrogensulfate
  • This reaction is usually carried out in a proper solvent (such as an inert solvent such as methylene chloride, chloroform, 1,2-dichloroethane, benzene, toluene, DMF or DMSO, or a water-containing solvent or a mixed solvent thereof) at a reaction temperature of from 0 to 50° C.
  • Each of metal atoms represented by M 3 and M 4 in Process 3 may, for example, be a typical metal atom such as lithium, magnesium, zinc or copper; or a transition metal atom such as palladium or ruthenium. Further, a composite salt of a metal atom may be used instead of a metal atom.
  • the compound of the formula (VI) wherein the substituent represented by M 3 is a formyl group and the compound of the formula (VII) wherein the substituent represented by M 4 is a formyl group may usually be produced in accordance with a known process such as a process as disclosed in Journal of Organic Chemistry vol. 57, pages 6847-6852, 1992.
  • the phenylpyridyl methanol represented by the formula (X), formed from the compound represented by the formula (VI) and the compound represented by the formula (VII), may be oxidized by a known means such as a metal oxidizing agent such as manganese dioxide or chromic acid, a Swern oxidation method (dimethylsulfoxide+oxalyl chloride) or a ruthenium oxidation method (tetrapropylammonium perruthenate+N-methylmorpholine-N-oxide) and converted to a compound represented by the formula (I)
  • a metal oxidizing agent such as manganese dioxide or chromic acid
  • a Swern oxidation method dimethylsulfoxide+oxalyl chloride
  • ruthenium oxidation method tetrapropylammonium perruthenate+N-methylmorpholine-N-oxide
  • R 2′ is a substitutable alkyl group, a substitutable alkoxy group, a substitutable aryloxy group, a substitutable cycloalkoxy group or a hydroxyl group, p is 1, 2 or 3; and R 2′′ is a substitutable alkoxy group or a hydroxyl group, provided that at least two of R 2′ and R 2′′ may contain an oxygen atom to form a condensed ring (excluding a case where the pyridine ring is substituted by a benzoyl group at the 2-position; the pyridine ring is substituted by an alkoxy group, a hydroxyl group or a benzyloxy group at the 3-position; and n is 1, p is 1).
  • X is a halogen atom, a nitro group, a substitutable alkoxy group, a substitutable aryloxy group, a substitutable cycloalkoxy group, a substitutable hydrocarbon group, a substitutable alkylthio group, a cyano group, a carboxyl group which may be esterified or amidated, or a substitutable amino group; n is 1, 2, 3 or 4; R 1 is an alkyl group; R 2′ is a substitutable alkyl group, a substitutable alkoxy group, a substitutable aryloxy group or a substitutable cycloalkoxy group, p is 1, 2 or 3, and each of R 2′′ and R 2′′′ is a substitutable alkoxy group.
  • X is a halogen atom, a substitutable alkoxy group, an alkyl group, a CF 3 group or an alkylthio group
  • n is 1, 2, 3 or 4
  • R 1 is an alkyl group
  • R 2′ is a substitutable alkyl group, a substitutable alkoxy group or a substitutable cycloalkoxy group
  • p is 1, 2 or 3
  • each of R 2′′ and R 2′′′ is a substitutable alkoxy group.
  • X is a halogen atom, an alkoxy group, an alkyl group, a CF 3 group or an alkylthio group; n is 1, 2 or 3; R 1 is an alkyl group; R 2 ′ is an alkoxy group; p is 1, 2 or 3; and each of R 2′′ and R 2′′′ is an alkoxy group.
  • B is —CX 4 ⁇ when A is —N ⁇ ; B is —N ⁇ when A is —CH ⁇ ; each of X 1 and X 2 which are independent of each other, is a halogen atom, an alkoxy group, an alkyl group, a CF 3 group or an alkylthio group;
  • X 3 is a hydrogen atom, a halogen atom, an alkoxy group, an alkyl group, a CF 3 group or an alkylthio group;
  • X 4 is a hydrogen atom, a halogen atom, an alkoxy group, an alkyl group, a CF 3 group or an alkylthio group;
  • R 1 is an alkyl group;
  • R 2 ′ is an alkoxy group;
  • a substituent may further be introduced into the compound represented by the formula (I) electrophilically or nucleophilically. That is, the compound represented by the formula (I) may be converted into a compound represented by the formula (I-a) or (I-b) as illustrated in the following scheme. Further, it is also possible to radically introduce a substituent into the compound represented by the formula (I).
  • E is an electrophilic reagent
  • Nu is a nucleophilic reagent.
  • n′ and n′′ are as defined for the above n.
  • the reaction to prepare the compound represented by the formula (I-a) varies properly depending upon the electrophile, and the reaction may usually be carried out by a known process or a process in accordance therewith.
  • the above-described Process 1 may be employed.
  • the nucleophilic substitution to prepare the compound represented by the formula (I-b) varies properly depending upon the nucleophile, and the reaction may usually be carried out by a known process or a process in accordance therewith.
  • an ethyloxy nucleophilic reagent it is preferred to carry out the reaction in the presence of an inert solvent such as ethanol or dioxane, toluene or octane as the solvent, at a reaction temperature of from 0 to 120° C. for a proper time.
  • the ethyloxy nucleophilic reagent is used in from 0.1 to 10 mol equivalent amount, preferably in from 0.5 to 5 mol equivalent amount.
  • the compound represented by the formula (I-c) (the compound of the formula (I) wherein X is a halogen atom) may further be converted into a compound represented by the formula (I-d) by removing the halogen substituent, as shown in the following scheme.
  • catalytic hydrogenation, hydrogen transfer reaction or metal reduction reaction may properly be employed.
  • Hal is a halogen atom.
  • the catalytic hydrogenation may be carried out in the presence of a catalyst under hydrogen gas atmosphere under normal pressure or under elevated pressure in the presence of a proper solvent.
  • the catalyst to be used may, for example, be a catalyst system having platinum, palladium, rhodium, ruthenium, nickel or iridium.
  • the solvent to be used may, for example, be water, an alcohol (such as methanol or ethanol), ethyl acetate, acetic acid, dioxane, ether, benzene or hexane. In such a case, the catalyst is used in a proportion of from 0.01 to 1.2 mol based on the compound represented by the formula (I-c).
  • reaction may be carried out in the presence of a base such as triethylamine or sodium hydrogen carbonate.
  • a known reduction reaction may be employed such as hydrogen transfer reaction (e.g. palladium carbon, ammonium formate as a hydrogen source, or sodium dihydrogen phosphate) or a metal reduction reaction (e.g. samarium diiodide).
  • step (b) 14 g of manganese dioxide was added to a solution having 5.4 g of (2,3,4-trimethoxy-6-methylphenyl)(2,6-dichloro-4-trifluoromethyl-3-pyridyl)methanol obtained in step (a) dissolved in 140 ml of toluene, followed by stirring under reflux by heating for 6 hours. The mixture was cooled and then subjected to filtration, and toluene was distilled off under reduced pressure to obtain 4.4 g (yield 81%) of 3-(2,3,4-trimethoxy-6-methylbenzoyl)-2,6-dichloro-4-trifluoromethylpyridine (compound No. 3; m.p. 81-83° C.).
  • step (b) 2.7 ml (19 mmol) of triethylamine and 0.9 g of 5% palladium carbon were added to a solution having (2,3,4-trimethoxy-6-methylphenyl)(2,3,6-trichloro-5-trifluoromethyl-4-pyridyl)methanol obtained in step (a) dissolved in 200 ml of methanol, followed by stirring under hydrogen atmosphere for 14 hours. The mixture was subjected to filtration, 30 ml of water was added thereto, and methanol was distilled off under reduced pressure. Extraction with ethyl acetate was carried out, the organic layer was dried over anhydrous sodium sulfate and subjected to filtration, and the solvent was distilled off under reduced pressure.
  • step (c) 14 g of manganese dioxide was added to a solution having 3.5 g (8.2 mmol) of (2,3,4-trimethoxy-6-methylphenyl)(2,915 5-dichloro-3-trifluoromethyl-4-pyridyl)methanol obtained in step (b) dissolved in 100 ml of toluene, followed by stirring under reflux by heating for 6 hours. The mixture was cooled and then subjected to filtration, and toluene was distilled off under reduced pressure.
  • step (d) Using 1.5 g (4.3 mmol) of (2-methyl-4,5-(methylenedioxy)phenyl)(2-chloro-4-trifluoromethyl-3-pyridyl)methanol obtained in step (c) and 8.0 g (92 mmol) of manganese dioxide, 0.3 g (yield 22%) of 3-[4,5-(methylenedioxy)-2-methylbenzoyl]-2-chloro-4-trifluoromethylpyridine (compound No. 13; m.p. 119-122° C.) was obtained by a process in accordance with step (b) of Synthesis Example 1.
  • the reaction solution was poured into an aqueous ammonium chloride solution (200 ml), and extraction with ethyl acetate (150 ml) was carried out twice.
  • the ethyl acetate phase was washed with an aqueous sodium chloride solution (100 ml) twice and dried over magnesium sulfate, and the solvent was distilled off under reduced pressure.
  • the residue was purified by silica gel column chromatography (hexane-ethyl acetate) to obtain 3.14 g (yield 48%) of 5-benzyloxy-4-methoxy-2-methylbenzaldehyde (m.p. 107-109° C.), and its structure was confirmed by nuclear magnetic resonance spectrum.
  • step (b) 10 g of manganese dioxide was added to a toluene (80 ml) solution of 2.3 g (5 mmol) of (2,3,4-trimethoxy-6-methylphenyl)(2,6-dichloro-5-(1-hydroxyethyl)-4-trifluoromethyl-3-pyridyl)methanol obtained in step (a), followed by stirring under reflux by heating for 1 hour.
  • the reaction solution was cooled to room temperature and then subjected to filtration, and toluene was distilled off under reduced pressure.
  • step (b) 2.1 g of 5% palladium carbon was added to a methanol 200 ml solution of 24.8 g (58.1 mmol) of (2,3,4-trimethoxy-6-methylphenyl)(2,3-dichloro-5-trifluoromethyl-4-pyridyl)methanol obtained in step (a) and 9.50 ml (68.2 mmol) of triethylamine, followed by stirring under hydrogen atmosphere for 4 hours. The mixture was subjected to filtration, 50 ml of water was added thereto, and methanol was distilled off under reduced pressure.
  • the aqueous layer was extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and subjected to filtration, and the solvent was distilled off under reduced pressure.
  • the crude product thus obtained was purified by silica gel column chromatography to obtain 15.9 g (yield 70%) of (2,3,4-trimethoxy-6-methylphenyl)(3-chloro-5-trifluoromethyl-4-pyridyl)methanol (m.p. 102-105° C.).
  • step (c) 45 g of manganese dioxide was added to a toluene 220 ml solution of 15.9 g (40.6 mmol) of (2,3,4-trimethoxy-6-methylphenyl)(3-chloro-5-trifluoromethyl-4-pyridyl)methanol obtained in step (b), followed by stirring under reflux by heating for 2 hours. The mixture was subjected to filtration, and the solvent was distilled off under reduced pressure to obtain 14.9 g (yield 94%) of 4-(2,3,4-trimethoxy-6-methylbenzoyl)-3-chloro-5-trifluoromethylpyridine (compound No. 102; m.p. 75-77° C.).
  • step (d) 16.4 g (304 mmol) of sodium methoxide was added to a toluene 150 ml solution of 18.5 g (47.5 mmol) of 4-(2,3,4-trimethoxy-6-methylbenzoyl)-3-chloro-5-trifluoromethylpyridine obtained in step (c) and 16.6 ml (95.4 mmol) of hexamethylphosphoric triamide, followed by stirring under reflux by heating for 30 minutes. Water was added thereto to terminate the reaction, the aqueous layer was extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and subjected to filtration, and the solvent was distilled off under reduced pressure.
  • step (b) 16.2 g of manganese dioxide was added to a toluene (180 ml) solution of 5.6 g of (2,3,4-trimethoxy-6-methylphenyl)(2,3,5-trichloro-4-pyridyl)methanol obtained in step (a), followed by stirring under reflux by heating for 3 hours. After the mixture was cooled, it was subjected to filtration, and the solvent was distilled off under reduced pressure to obtain 4.7 g (yield 87%) of 4-(2,3,4-trimethoxy-6-methylbenzoyl)-2,3,5-trichloropyridine (compound No. 186; m.p. 60-61° C.).
  • step (b) A tetrahydrofuran (15 ml) solution of 2.0 g (4.6 mmol) of (2,3,4-trimethoxy-6-methylphenyl)(3,5-dibromo-4-pyridyl)methanol obtained in step (a) was cooled to ⁇ 78° C., 6.0 ml (9.4 mmol) of n-butyllithium (1.56 M hexane solution) was dropwise added thereto, followed by stirring for 5 minutes, and 0.5 ml (8.0 mmol) of methyl iodide was added thereto, followed by stirring for 2.5 hours. 20 ml of water was added, and tetrahydrofuran was distilled off under reduced pressure.
  • the aqueous layer was extracted with ethyl acetate, the organic layer was dried over anhydrous sodium sulfate and subjected to filtration, and the solvent was distilled off under reduced pressure.
  • the crude product thus obtained was purified by silica gel column chromatography to obtain 0.44 g (yield 25%) of (2,3,4-trimethoxy-6-methylphenyl)(3-bromo-5-methyl-4-pyridyl)methanol.
  • step (c) 3 g of manganese dioxide was added to a toluene (30 ml) solution of 0.43 g (1.1 mmol) of (2,3,4-trimethoxy-6-methylphenyl)(3-bromo-5-methyl-4-pyridyl)methanol obtained in step (b), followed by stirring under reflux by heating for 2 hours.
  • the mixture was subjected to filtration, the solvent was distilled off under reduced pressure, and the crude product thus obtained was purified by silica gel column chromatography to obtain 0.23 g (yield 54%) of 4-(2,3,4-trimethoxy-6-methylbenzoyl)-3-bromo-5-methylpyridine (compound No. 228; m.p. 88-93° C.).
  • a dry methylene chloride (100 ml) solution of 128 g (0.7 mol) of 3,4,5-trimethoxytoluene was dropwise added to a dry methylene chloride 500 ml solution of 112 g (0.84 mol) of aluminum chloride gradually under cooling with ice.
  • the mixture was stirred at the same temperature for 45 minutes, a dry methylene chloride solution of 88.5 g (0.77 mol) of dichloromethyl methyl ether was dropwise added thereto gradually over a period of 2 hours. Stirring was conducted at the same temperature for 2 hours, and the mixture was gradually recovered to room temperature, followed by stirring at room temperature for one night.
  • the reaction mixture was poured into 1 l of ice water, the methylene chloride phase was separated, and the aqueous phase was extracted with 200 ml of methylene chloride twice.
  • the extract and the methylene chloride phase were combined together, sequentially washed with 200 ml of water, 200 ml of a saturated aqueous sodium bicarbonate solution and 200 ml of a saturated aqueous sodium chloride solution and dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure.
  • a seed for a crystal was inoculated into the residue, and the resulting crystal was collected by filtration, washed with hexane and air dried to obtain 128 g of 2,3,4-trimethoxy-6-methylbenzaldehyde (m.p. 55-57° C.).
  • compounds represented by the formulae (I-1) to (I-9) in Tables are the following compounds. Further, in Tables, Me represents a methyl group, Et represents an ethyl group, Butyl represents a butyl group, i-Propyl represents an isopropyl group, Ph represents a phenyl group, Allyl represents an allyl group, c-Hexyl represents a cyclohexyl group, Benzyl represents a benzyl group, Propargyl represents a propargyl group, and Pentyl represents a pentyl group.
  • 6′-MeO 93 2-MeO, 5-Cl Me 4′-MeO, 5′-MeO, m.p.130-134° C.
  • 6′-MeO 94 2-MeO 5-Cl Me 4′-MeO, 5′-MeO m.p.151-156° C.
  • 6′-MeO 100 5-Cl, 6-Cl Me 4′-MeO, 5′-MeO m.p.94-97° C. 101 5-Cl Me 4′-MeO, 5′-MeO m.p.90-91° C. 102 5-Cl Me 4′-MeO, 5′-MeO, m.p.75-77° C. 6′-MeO 103 5-Cl, 6-Cl Me 4′-MeO, 5′-MeO, m.p.72-74° C. 6′-MeO 104 5-Cl, 6-MeO Me 4′-MeO, 5′-MeO, m.p.143-146° C.
  • 6′-MeO 105 5-Cl, 6-MeO Me 4′-MeO, 5′-MeO m.p.112-115° C. 106 5-Cl, 6-EtO Me 4′-MeO, 5′-MeO, m.p.82-84° C.
  • 6′-MeO 107 6-MeO Me 4′-MeO, 5′-MeO, Pale yellow oily 6′-MeO substance 108 5-Cl, 6-n-Propyl—O Me 4′-MeO, 5′-MeO, Pale yellow oily 6′-MeO substance 109 6-EtO Me 4′-MeO, 5′-MeO, Pale yellow oily 6′-MeO substance 110 5-Cl, 6-n-Butyl—O Me 4′-MeO, 5′-MeO, Pale yellow oily 6′-MeO substance 111 6-n-Propyl—O Me 4′-MeO, 5′-MeO, Pale yellow oily 6′-MeO substance 112 6-n-Butyl—O Me 4′-MeO, 5′-MeO, Pale yellow oily 6′-MeO substance
  • 6′-MeO 116 6-n-Pentyl—O Me 4′-MeO, 5′-MeO, Pale yellow 6′-MeO oily substance 117 5-Cl, Me 4′-MeO, 5′-MeO, m.p.62-64° C. 6-CH 3 S(CH 2 ) 2 O 6′-MeO 118 5-Cl, 6-Allyl—O Me 4′-MeO, 5′-MeO, Pale yellow 6′-MeO oily substance 119 5-Cl, Me 4′-MeO, 5′-MeO, m.p.78-80° C.
  • Me represents a methyl group
  • Et represents an ethyl group
  • Butyl represents a butyl group
  • i-Propyl represents an isopropyl group
  • Ph represents a phenyl group
  • Allyl represents an allyl group
  • c-Hexyl represents a cyclohexyl group
  • Benzyl represents a benzyl group
  • Propargyl represents a propargyl group
  • Pentyl represents a pentyl group.
  • 6′-MeO 104 5-Cl, 6-MeO Me 4′-MeO, 5′-MeO, 6′-MeO 105 5-Cl, 6-MeO Me 4′-MeO, 5′-MeO 106 5-Cl, 6-EtO Me 4′-MeO, 5′-MeO, 6′-MeO 107 6-MeO Me 4′-MeO, 5′-MeO, 6′-MeO 108 5-Cl, Me 4′-MeO, 5′-MeO, 6-n-Propyl—O 6′-MeO 109 6-EtO Me 4′-MeO, 5′-MeO, 6′-MeO 110 5-Cl, Me 4′-MeO, 5′-MeO, 6-n-Butyl—O 6′-MeO 111 6-n-Propyl—O Me 4′-MeO, 5′-MeO, 6′-MeO 112 6-n-But
  • the benzoylpyridine derivative represented by the formula (I) or its salt is useful as an active ingredient for a fungicide, particularly as an active ingredient for an agricultural and horticultural fungicide.
  • a fungicide particularly as an active ingredient for an agricultural and horticultural fungicide.
  • it is effective for controlling diseases such as blast, brown spot or sheath blight of rice ( Oryza sativa ); powdery mildew, scab, rust, snow mold, loose smut, eyespot, leaf spot or glume blotch of barley ( Hordeum vulgare ); melanose or scab of citrus (Citrus); blossom blight, powdery mildew, Altenaria leaf spot or scab of apple ( Malus pumila ); scab or black spot of pear ( Pyrus serotina, Pyrus ussuriensis, Pyrus communis ); brown rot, scab or Fomitopsis rot of peach ( Prunus persica ); Anthracnose
  • the compound of the present invention may be used in combination with an agricultural adjuvant to formulate various preparations of the fungicide containing the compound, such as a dust, granules, a granular wettable powder, a wettable powder, an aqueous suspension, an oil suspension, a water soluble powder, an emulsifiable concentrate, an aqueous solution, a paste, an aerosol or a microdose dusting powder.
  • an agricultural adjuvant to formulate various preparations of the fungicide containing the compound, such as a dust, granules, a granular wettable powder, a wettable powder, an aqueous suspension, an oil suspension, a water soluble powder, an emulsifiable concentrate, an aqueous solution, a paste, an aerosol or a microdose dusting powder.
  • the compound of the present invention may be formed into any preparation which is usually used in the agricultural and horticultural field so long as the purpose of the present invention is met.
  • the adjuvant to be used for preparation may, for example, be a solid carrier such as diatomaceous earth, hydrated lime, calcium carbonate, talc, white carbon, kaolin, bentonite, a mixture of kaolinite and sericite, clay, sodium carbonate, sodium bicarbonate, glauber's salt, zeolite or starch; a solvent such as water, toluene, xylene, solvent naphtha, dioxane, acetone, isophorone, methyl isobutyl ketone, chlorobenzene, cyclohexane, dimethylsulfoxide, dimethylformamide, dimethylacetamide, N-methyl-2-pyrrolidone or an alcohol; an anionic surfactant or spreading agent such as a fatty acid salt, a benzoate, an alkyl sulfosuccinate, a dialkyl sulfosuccinate, a polycarboxylate, an alkyl sulfuric ester salt,
  • a known adjuvant may be selected from adjuvants which are known in the agricultural and horticultural field within a range of not departing from the object of the present invention. Further, an adjuvant which is usually used may also be employed, such as a bulking agent, a thickener, an anti-settling agent, a freeze proofing agent, a dispersion stabilizer, a crop injury-reducing agent or a mildewproofing agent.
  • the blending proportion of the compound of the present invention to the adjuvant is generally from 0.005:99.995 to 95:5, preferably from 0.2:99.8 to 90:10. These formulations can be practically used either as they are or after they are diluted with a diluent such as water to predetermined concentrations and a spreading agent is added thereto as the case requires.
  • the concentration of the compound of the present invention varies depending upon the crop plant as the object, the way of application, the form of preparation or the dose, and hence cannot be generically determined.
  • the concentration of the compound as the active ingredient is generally from 0.1 to 10,000 ppm, preferably from 1 to 2,000 ppm.
  • the concentration of the compound as the active ingredient is generally from 10 to 100,000 g/ha, preferably from 200 to 20,000 g/ha.
  • the preparation fungicide containing the compound of the present invention or a diluted product thereof can be applied by an application method which is commonly used, such as spreading (spreading, spraying, misting, atomizing, grain diffusing or application on water), soil application (such as mixing or irrigation) or surface application (such as coating, dust coating or covering). Further, it may be applied also by so-called ultra low volume.
  • the preparation can contain 100% of the active ingredient.
  • the fungicide of the present invention may be mixed or used together with e.g. another agricultural chemical such as an insecticide, a miticide, a nematicide, a fungicide, an antiviral agent, an attractant, an herbicide or a plant growth regulator. In such a case, a still more excellent effect may be obtained in some cases.
  • Examples of the active ingredient compound (generic name; including compounds which are under application) of the insecticide, miticide or nematicide i.e. a pesticide of the above other agricultural chemicals, include organic phosphate type compounds such as Profenofos, Dichlorvos, Fenamiphos, Fenitrothion, EPN, Diazinon, Chlorpyrifos-methyl, Acephate, Prothiofos, Fosthiazate, Phosphocarb, Cadusafos and Dislufoton;
  • carbamate type compounds such as Carbaryl, Propoxur, Aldicarb, Carbofuran, Thiodicarb, Methomyl, Oxamyl, Ethiofencarb, Pirimicarb, Fenobucarb, Carbosulfan and Benfuracarb;
  • nelicetoxin derivatives such as Cartap and Thiocyclam
  • organic chlorine type compounds such as Dicofol and Tetradifon;
  • organic metal type compounds such as Fenbutatin Oxide
  • pyrethroid type compounds such as Fenvalerate, Permethrin, Cypermethrin, Deltamethrin, Cyhalothrin, Tefluthrin, Ethofenprox and Flufenprox;
  • benzoyl urea type compounds such as Diflubenzuron, Chlorfluazuron, Teflubenzuron and Flufenoxuron;
  • pyridazinone type compounds such as Pyridaben
  • pyrazole type compounds such as Fenpyroximate, Fipronil, Tebufenpyrad, Ethiprole, Tolefenpyrad and Acetoprole;
  • neonicotinoides such as Imidacloprid, Nitenpyram, Acetamiprid, Thiacloprid, Thiamethoxam, Clothianidin, Nidinotefuran and Dinotefuran;
  • hydrazine type compounds such as Tebufenozide, Methoxyfenozide and Chromafenozide;
  • pyridine type compounds such as Pyridaryl and Flonicamid
  • tetronic acid type compounds such as Spirodiclofen
  • strobilurin type compounds such as Fluacrypyrin
  • dinitro type compounds dinitro type compounds, organosulfur compounds, urea type compounds, triazine type compounds, hydrozone type compounds and other compounds such as Buprofezin, Hexythiazox, Amitraz, Chlordimeform, Silafluofen, Triazamate, Pymetrozine, Pyrimidifen, Chlorfenapyr, Indoxacarb, Acequinocyl, Etoxazole, Cyromazine and 1,3-dichloropropene; AKD-1022 and IKA-2000.
  • Buprofezin Hexythiazox
  • Amitraz Chlordimeform
  • Silafluofen Triazamate
  • Pymetrozine Pyrimidifen
  • Chlorfenapyr Indoxacarb
  • Acequinocyl Etoxazole
  • Cyromazine and 1,3-dichloropropene AKD-1022 and IKA-2000.
  • the fungicide of the present invention may also be mixed or used together with a microbial pesticide such as a BT agent or an insect pathogenic virus agent or an antibiotic such as Avermectin, Milbemycin, Spinosad or Emamectin Benzoate.
  • a microbial pesticide such as a BT agent or an insect pathogenic virus agent or an antibiotic such as Avermectin, Milbemycin, Spinosad or Emamectin Benzoate.
  • examples of the active ingredient compounds of the fungicides include pyrimidinamine type compounds such as Mepanipyrim, Pyrimethanil and Cyprodinil, pyridinamine type compound such as Fluazinam;
  • azole type compounds such as Triadimefon, Bitertanol, Triflumizole, Etaconazole, Propiconazole, Penconazole, Flusilazole, Myclobutanil, Cyproconazole, Terbuconazole, Hexaconazole, Furconazole-cis, Prochloraz, Metconazole, Epoxiconazole, Tetraconazole, Oxpoconazole fumarate and Sipconazole;
  • quinoxaline type compounds such as Quinomethionate
  • dithiocarbamate type compounds such as Maneb, Zineb, Mancozeb, Polycarbamate, Metiram and Propineb;
  • organic chlorine type compounds such as Fthalide, Chlorothalonil and Quintozene
  • imidazole type compounds such as Benomyl, Thiophanate-Methyl, Carbendazim and Cyazofamid;
  • cyanoacetamide type compounds such as Cymoxanil
  • phenylamide type compounds such as Metalaxyl, Metalaxyl M, oxadixyl, Ofurace, Benalaxyl, Furalaxyl and Cyprofuram;
  • sulfenic acid type compounds such as Dichlofluanid
  • copper type compounds such as Cupric hydroxide and Oxine Copper
  • isoxazole type compounds such as Hydroxyisoxazole
  • organophosphorus compounds such as Fosetyl-Al, Tolcofos-Methyl, S-benzyl O-diisopropylphosphorothioate, O-ethyl S,S-diphenylphosphorodithioate and aluminum ethyl hydrogen phosphonate;
  • N-halogenothioalkyl type compounds such as Captan, Captafol and Folpet;
  • dicarboxyimide type compounds such as Procymidone, Iprodione and Vinclozolin;
  • benzanilide type compounds such as Flutolanil, Mepronil and Zoxamid;
  • piperazine type compounds such as Triforine
  • pyridine type compounds such as Pyrifenox
  • carbionol type compounds such as Fenarimol and Flutriafol
  • piperidine type compounds such as Fenpropidine
  • morpholine type compounds such as Fenpropimorph
  • organotin type compounds such as Fentin Hydroxide and Fentin Acetate
  • urea type compounds such as Pencycuron
  • cinnamic acid type compounds such as Dimethomorph
  • phenyl carbamate type compounds such as Diethofencarb
  • cyanopyrrole type compounds such as Fludioxonil and Fenpiclonil;
  • strobilurin type compounds such as Azoxystrobin, Kresoxim-Methyl, Metominofen, Triflouxystrobin, Picoxystrobin and Pyraclostrobin: (BAS 500F); oxazolidinone type compounds such as Famoxadone; thiazole carboxamide type compounds such as Ethaboxam;
  • silyl amide type compounds such as Silthiopham; aminoacid amidecarbamate type compounds such as Iprovalicarb and Benthiavalicarb; Imidazolidine type compounds such as fenamidone; hydroxyanilide type compounds such as Fenhexamid; benzene sulfonamide type compounds such as Flusulfamid; oxime ether type compounds such as Cyflufenamid; phenoxyamide type compounds such as Fenoxanil; triazole type compounds such as Simeconazole;
  • anthraquinone type compounds crotonic acid type compounds
  • antibiotics and other compounds such as Isoprothiolane, Tricyclazole, Pyroquilon, Diclomezine, Pro. benazole, Quinoxyfen, Propamocarb Hydrochloride, Spiroxamine, Chloropicrin, Dazomet and Metam-sodium; and BJL-993, BJL-994, BAS-510, BAS-505, MTF-753 and UIBF-307.
  • Wheat (cultivar: Norin-61-go) was cultivated in a polyethylene pot having a diameter of 7.5 cm, and when the wheat reached a one and a half-leaf stage, the wheat was sprayed with 10 ml of a drug solution having a predetermined concentration of the compound of the present invention by a spray gun. After the drug solution dried, the wheat was inoculated by spreading with conidiospore of fungi of powdery mildew, and the wheat was kept in a thermostatic chamber at 20° C. From 6 to 8 days after the inoculation, the area of sporogony was examined to determine the controlling index in accordance with the above evaluation standards. As a result, of the above compounds, compounds Nos.
  • Rice (cultivar: Nihonbare) was calculated in a polyethylene pot having a diameter of 7.5 cm, and when the rice reached a one and a half-leaf stage, the rice was sprayed with 10 ml of a drug solution having a predetermined concentration of the compound of the present invention by a spray gun. After the drug solution dried, the rice was sprayed and inoculated with a conidiospore suspension of fungi of rice blast, and the rice was kept in an inoculation box at 20° C. for 24 hours, and then kept in a thermostatic chamber at 20° C. From 6 to 11 days after the inoculation, the number of lesions was examined to determine the controlling index in accordance with the above evaluation standards.
  • the compounds Nos. 31, 56, 76, 90, 103 and 136 showed effects with a controlling index of 4 or above at a concentration of 500 ppm, and the compounds Nos. 50, 74, 75 and 102 showed effects with a controlling index of 4 or above at a concentration of 125 ppm.
  • Eggplant (cultivar: Senryo-2-go) was cultivated in a polyethylene pot having a diameter of 7.5 cm, and when the eggplant reached a two-leaf stage, the eggplant was sprayed with 10 ml of a drug solution having a predetermined concentration of the compound of the present invention by a spray gun. After the drug solution dried, the eggplant was inoculated by spreading with conidiospore of fungi of eggplant powdery mildew, and the eggplant was kept in a thermostatic chamber at 20° C. 16 days after the inoculation, the area of sporogony was examined to determine the controlling index in accordance with the above evaluation standards. As a result, of the above compounds, compounds Nos.
  • Cucumber (cultivar: Suyo) was cultivated in a polyethylene pot having a diameter of 7.5 cm, and when the cucumber reached one and a half-leaf stage, the cucumber was sprayed with a 10 ml of a drug solution having a predetermined concentration of the compound of the present invention by a spray gun. After the drug solution dried, the cucumber was sprayed and inoculated with a conidiospore suspension of fungi of powdery mildew, and the cucumber was kept in a thermostatic chamber at 20° C. From 7 to 11 days after the inoculation, the area of sporogony was examined to determine the controlling index in accordance with the above evaluation standards. As a result, of the above compounds, the compound No.
  • the above components are uniformly mixed to obtain a wettable powder.
  • the above components are uniformly mixed to obtain a dust.
  • Clay 68 parts by weight (2) Sodium lignin sulfonate 2 parts by weight (3) Polyoxyethylene alkyl aryl sulfate 5 parts by weight (4) Fine silica 25 parts by weight
  • a mixture of the above components and the compound of the present invention are mixed in a weight ratio of 4:1 to obtain a wettable powder.
  • Compound of the present invention 50 parts by weight (2) Oxylated polyalkylphenyl phosphate- 2 parts by weight triethanolamine (3) Silicone 0.2 part by weight (4) Water 47.8 parts by weight
  • the above components (1) to (3) are preliminarily mixed uniformly and diluted with a proper amount of acetone, the diluted mixture is sprayed on the component (4), and acetone is removed to obtain granules.
  • the above components are uniformly mixed and dissolved to obtain an ultra low volume formulation.
  • the above components are uniformly mixed and pulverized to obtain an aqueous suspension.
  • the benzoylpyridine derivative represented by the formula (I) or its salt has excellent effects as an active ingredient of a fungicide.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
US10/312,040 2000-07-05 2001-07-05 Benzoylpyridine derivative or its salt, fungicide containing it as an active ingredient, its production process and intermediate for producing it Expired - Lifetime US6770662B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2000203909 2000-07-05
JP2000-203909 2000-07-05
JP2001-034182 2001-02-09
JP2001034182 2001-02-09
JP2001094222 2001-03-28
JP2001-094222 2001-03-28
PCT/JP2001/005851 WO2002002527A1 (en) 2000-07-05 2001-07-05 Benzoylpyridine derivative or its salt, fungicide containing it as an active ingredient, its production process and intermediate for producing it

Publications (2)

Publication Number Publication Date
US20030216444A1 US20030216444A1 (en) 2003-11-20
US6770662B2 true US6770662B2 (en) 2004-08-03

Family

ID=27343965

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/312,040 Expired - Lifetime US6770662B2 (en) 2000-07-05 2001-07-05 Benzoylpyridine derivative or its salt, fungicide containing it as an active ingredient, its production process and intermediate for producing it

Country Status (28)

Country Link
US (1) US6770662B2 (hu)
EP (1) EP1296952B9 (hu)
KR (1) KR100760124B1 (hu)
CN (1) CN100336807C (hu)
AR (1) AR029289A1 (hu)
AT (1) ATE372984T1 (hu)
AU (2) AU2001269456B2 (hu)
BR (1) BR0112199B1 (hu)
CA (1) CA2412282C (hu)
CY (1) CY1107010T1 (hu)
DE (1) DE60130454T2 (hu)
DK (1) DK1296952T3 (hu)
EG (1) EG22882A (hu)
ES (1) ES2296767T3 (hu)
FR (1) FR15C0008I2 (hu)
HU (2) HU230070B1 (hu)
IL (1) IL153779A0 (hu)
LU (1) LU93106I2 (hu)
MA (1) MA25827A1 (hu)
ME (1) MEP10308A (hu)
MX (1) MXPA02012875A (hu)
MY (1) MY127330A (hu)
NL (1) NL350079I2 (hu)
PL (1) PL209746B1 (hu)
PT (1) PT1296952E (hu)
RS (1) RS50913B (hu)
TW (1) TWI286548B (hu)
WO (1) WO2002002527A1 (hu)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060089390A1 (en) * 2002-10-31 2006-04-27 Ishihara Sangyo Kaisha, Ltd. 3-benzoyl-2,4,5-substituted pyridine derivatives or salts thereof and bactericides containing the same
US20060194849A1 (en) * 2003-10-31 2006-08-31 Ishihara Sangyo Kaisha, Ltd. Fungicidal composition and method for controlling plant diseases
US20090124602A1 (en) * 2007-01-31 2009-05-14 Francois Maltais Kinase inhibitors
US20090291937A1 (en) * 2007-11-02 2009-11-26 Juan-Miguel Jimenez Kinase inhibitors
US20110183966A1 (en) * 2008-08-06 2011-07-28 Vertex Pharmaceuticals Incorporated Aminopyridine kinase inhibitors
US8541445B2 (en) 2009-05-06 2013-09-24 Vertex Pharmaceuticals Incorporated Pyrazolopyridines
US8563576B2 (en) 2008-07-23 2013-10-22 Vertex Pharmaceuticals Incorporated Tri-cyclic pyrazolopyridine kinase inhibitors
US8569337B2 (en) 2008-07-23 2013-10-29 Vertex Pharmaceuticals Incorporated Tri-cyclic pyrazolopyridine kinase inhibitors
KR101368013B1 (ko) * 2006-07-05 2014-02-26 이시하라 산교 가부시끼가이샤 살균제 조성물 및 식물 병해의 방제 방법
US8809335B2 (en) 2010-01-27 2014-08-19 Vertex Pharmaceuticals Incorporated Pyrazolopyrimidine kinase inhibitors
US8895740B2 (en) 2010-01-27 2014-11-25 Vertex Pharmaceuticals Incorporated Pyrazolopyrazine kinase inhibitors
US8962661B2 (en) 2008-07-03 2015-02-24 Ishihara Sangyo Kaisha, Ltd. Fungicidal composition and method for controlling plant diseases
US9067932B2 (en) 2010-01-27 2015-06-30 Vertex Pharmaceuticals Incorporated Pyrazolopyridine kinase inhibitors
US9137973B2 (en) 2008-07-23 2015-09-22 Vertex Pharmaceuticals Incorporated Pyrazolopyridine kinase inhibitors
US10015964B2 (en) 2011-07-08 2018-07-10 Ishihara Sangyo Kaisha, Ltd. Fungicidal composition and method for controlling plant diseases
US11950592B2 (en) 2016-04-15 2024-04-09 Ishihara Sangyo Kaisha, Ltd. Method for enhancing plant disease controlling effects of aryl phenyl ketone fungicide, and method for controlling plant diseases

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100581362C (zh) * 2003-10-31 2010-01-20 石原产业株式会社 杀菌剂组合物和植物病害的防除方法
AU2012216657B2 (en) * 2003-10-31 2013-09-12 Ishihara Sangyo Kaisha, Ltd. Bactericide composition and method of controlling plant disease
TW201002202A (en) * 2008-06-27 2010-01-16 Du Pont Fungicidal pyridines
CA2785169C (en) 2009-12-22 2016-11-22 Mitsui Chemicals Agro, Inc. Plant disease control composition and method for controlling plant disease by applying the same
EP2481284A3 (en) 2011-01-27 2012-10-17 Basf Se Pesticidal mixtures
JP5940368B2 (ja) 2011-05-24 2016-06-29 石原産業株式会社 殺菌剤組成物及び植物病害の防除方法
JP5940369B2 (ja) 2011-05-27 2016-06-29 石原産業株式会社 植物病害の防除方法
CN103181390B (zh) * 2011-12-31 2014-06-18 深圳诺普信农化股份有限公司 一种含二芳基酮化合物的杀菌组合物
JP2014015449A (ja) 2012-06-13 2014-01-30 Ishihara Sangyo Kaisha Ltd 殺菌剤組成物及び植物病害の防除方法
CN105076143A (zh) * 2014-05-21 2015-11-25 深圳诺普信农化股份有限公司 杀菌组合物
CN105076137A (zh) * 2014-05-21 2015-11-25 深圳诺普信农化股份有限公司 一种杀菌组合物
EP3428151A4 (en) * 2016-03-09 2020-02-19 Nippon Soda Co., Ltd. PYRIDINE COMPOUND AND USE THEREOF

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0032516A1 (en) 1980-01-16 1981-07-29 Lacer, S.A. New 2-halo-pyridines, their production and pharmaceutical compositions
EP0177054A1 (de) 1984-10-05 1986-04-09 Richter Gedeon Vegyeszeti Gyar R.T. Neue Pyridinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
EP0177907A1 (de) 1984-10-05 1986-04-16 Richter Gedeon Vegyészeti Gyár R.T. Neue 2-Pyridin-thiol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
WO1994024106A1 (en) 1993-04-22 1994-10-27 Zeneca Limited Herbicidal (4-substituted pyridyl)-3-carbinols
JPH07309837A (ja) 1993-04-28 1995-11-28 Takeda Chem Ind Ltd ピリジン誘導体、その製造法および剤
EP0704435A1 (en) 1993-07-30 1996-04-03 Eisai Co., Ltd. Process for producing hydroquinone and benzoquinone derivative
WO1996017829A2 (en) 1994-12-06 1996-06-13 Zeneca Limited 3-benzoylpyridine derivatives, their preparation and their use as herbicides
WO1998006700A1 (en) 1996-08-09 1998-02-19 Merck & Co., Inc. Stereoselective deoxygenation reaction
EP0848000A1 (en) 1996-12-13 1998-06-17 Tanabe Seiyaku Co., Ltd. Pharmaceutical pyridine derivatives, processes for preparing the same and intermediates therefor
WO1999041237A1 (en) 1998-02-13 1999-08-19 G.D. Searle & Co. Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity
JP2000063275A (ja) 1998-06-12 2000-02-29 Tanabe Seiyaku Co Ltd 医薬組成物
WO2000015616A1 (en) 1998-09-16 2000-03-23 Dow Agrosciences Llc 2-methoxyimino-2-(pyridinyloxymethyl)phenyl acetamides with (derivatised) hydroxyalkyl derivatives on the pyridine ring
JP2001089412A (ja) 1999-09-22 2001-04-03 Otsuka Pharmaceut Co Ltd ベンゼン誘導体またはその医薬的に許容される塩

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU638020B2 (en) * 1989-06-15 1993-06-17 Medtronic, Inc. Improved glass-metal seals
JP2927161B2 (ja) * 1993-10-25 1999-07-28 ヤマハ株式会社 半導体メモリとその製法

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0032516A1 (en) 1980-01-16 1981-07-29 Lacer, S.A. New 2-halo-pyridines, their production and pharmaceutical compositions
EP0177054A1 (de) 1984-10-05 1986-04-09 Richter Gedeon Vegyeszeti Gyar R.T. Neue Pyridinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
EP0177907A1 (de) 1984-10-05 1986-04-16 Richter Gedeon Vegyészeti Gyár R.T. Neue 2-Pyridin-thiol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
WO1994024106A1 (en) 1993-04-22 1994-10-27 Zeneca Limited Herbicidal (4-substituted pyridyl)-3-carbinols
JPH07309837A (ja) 1993-04-28 1995-11-28 Takeda Chem Ind Ltd ピリジン誘導体、その製造法および剤
EP0704435A1 (en) 1993-07-30 1996-04-03 Eisai Co., Ltd. Process for producing hydroquinone and benzoquinone derivative
WO1996017829A2 (en) 1994-12-06 1996-06-13 Zeneca Limited 3-benzoylpyridine derivatives, their preparation and their use as herbicides
US5565413A (en) * 1994-12-06 1996-10-15 Zeneca Limited Substituted pyridyl phenyl ketone herbicides
WO1998006700A1 (en) 1996-08-09 1998-02-19 Merck & Co., Inc. Stereoselective deoxygenation reaction
EP0848000A1 (en) 1996-12-13 1998-06-17 Tanabe Seiyaku Co., Ltd. Pharmaceutical pyridine derivatives, processes for preparing the same and intermediates therefor
WO1999041237A1 (en) 1998-02-13 1999-08-19 G.D. Searle & Co. Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity
JP2000063275A (ja) 1998-06-12 2000-02-29 Tanabe Seiyaku Co Ltd 医薬組成物
WO2000015616A1 (en) 1998-09-16 2000-03-23 Dow Agrosciences Llc 2-methoxyimino-2-(pyridinyloxymethyl)phenyl acetamides with (derivatised) hydroxyalkyl derivatives on the pyridine ring
JP2001089412A (ja) 1999-09-22 2001-04-03 Otsuka Pharmaceut Co Ltd ベンゼン誘導体またはその医薬的に許容される塩

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Database CA 'Online! Chemical Abstracts Service, Columbus, Ohio, US Anna Arnoldi et al.: "Synthesis of some 3-phenyl-1-substituted(or 1,1-disubstituted)prop-2-yn-1-ols and their in vivo activity against some phytopathogenic fungi" retrieved from STN, database accession No. 99:153745 CA, XP002180437 abstract; RN 87446-23-9.
Masakatsu Sugahara et al.: "A synthesis of 1-pyridylnaphthalene lignan analogs" Tetrahedron Lett., vol. 39, No. 11, pp. 1377-1380 1998.

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060089390A1 (en) * 2002-10-31 2006-04-27 Ishihara Sangyo Kaisha, Ltd. 3-benzoyl-2,4,5-substituted pyridine derivatives or salts thereof and bactericides containing the same
US8609150B2 (en) 2003-10-31 2013-12-17 Ishihara Sangyo Kaisha, Ltd. Fungicidal composition and method for controlling plant diseases
US20060194849A1 (en) * 2003-10-31 2006-08-31 Ishihara Sangyo Kaisha, Ltd. Fungicidal composition and method for controlling plant diseases
US9655362B2 (en) 2003-10-31 2017-05-23 Ishihara Sangyo Kaisha, Ltd. Fungicidal composition and method for controlling plant diseases
US20090247763A1 (en) * 2003-10-31 2009-10-01 Ishihara Sangyo Kaisha, Ltd. Fungicidal composition and method for controlling plant diseases
US8653277B2 (en) 2003-10-31 2014-02-18 Ishihara Sangyo Kaisha, Ltd. Fungicidal composition and method for controlling plant diseases
US8653113B2 (en) 2003-10-31 2014-02-18 Ishihara Sangyo Kaisha, Ltd. Fungicidal composition and method for controlling plant diseases
KR101368013B1 (ko) * 2006-07-05 2014-02-26 이시하라 산교 가부시끼가이샤 살균제 조성물 및 식물 병해의 방제 방법
US8188071B2 (en) 2007-01-31 2012-05-29 Vertex Pharmaceuticals Incorporated Amino substituted pyridines as potent kinase inhibitors
US8741931B2 (en) 2007-01-31 2014-06-03 Juan-Miguel Jimenez Kinase inhibitors
US20090124602A1 (en) * 2007-01-31 2009-05-14 Francois Maltais Kinase inhibitors
US8367697B2 (en) 2007-11-02 2013-02-05 Vertex Pharmaceuticals Incorporated Kinase inhibitors
US8173635B2 (en) 2007-11-02 2012-05-08 Vertex Pharmaceuticals Incorporated Kinase inhibitors
US20090291937A1 (en) * 2007-11-02 2009-11-26 Juan-Miguel Jimenez Kinase inhibitors
US9474281B2 (en) 2008-07-03 2016-10-25 Ishihara Sangyo Kaisha, Ltd. Fungicidal composition and method for controlling plant diseases
US8962661B2 (en) 2008-07-03 2015-02-24 Ishihara Sangyo Kaisha, Ltd. Fungicidal composition and method for controlling plant diseases
US8569337B2 (en) 2008-07-23 2013-10-29 Vertex Pharmaceuticals Incorporated Tri-cyclic pyrazolopyridine kinase inhibitors
US8563576B2 (en) 2008-07-23 2013-10-22 Vertex Pharmaceuticals Incorporated Tri-cyclic pyrazolopyridine kinase inhibitors
US9137973B2 (en) 2008-07-23 2015-09-22 Vertex Pharmaceuticals Incorporated Pyrazolopyridine kinase inhibitors
US8815866B2 (en) 2008-08-06 2014-08-26 Vertex Pharmaceuticals Incorporated Aminopyridine kinase inhibitors
US8377926B2 (en) 2008-08-06 2013-02-19 Vertex Pharmaceuticals Incorporated Aminopyridine kinase inhibitors
US20110183966A1 (en) * 2008-08-06 2011-07-28 Vertex Pharmaceuticals Incorporated Aminopyridine kinase inhibitors
US8541445B2 (en) 2009-05-06 2013-09-24 Vertex Pharmaceuticals Incorporated Pyrazolopyridines
US8809335B2 (en) 2010-01-27 2014-08-19 Vertex Pharmaceuticals Incorporated Pyrazolopyrimidine kinase inhibitors
US8895740B2 (en) 2010-01-27 2014-11-25 Vertex Pharmaceuticals Incorporated Pyrazolopyrazine kinase inhibitors
US9067932B2 (en) 2010-01-27 2015-06-30 Vertex Pharmaceuticals Incorporated Pyrazolopyridine kinase inhibitors
US10015964B2 (en) 2011-07-08 2018-07-10 Ishihara Sangyo Kaisha, Ltd. Fungicidal composition and method for controlling plant diseases
US11950592B2 (en) 2016-04-15 2024-04-09 Ishihara Sangyo Kaisha, Ltd. Method for enhancing plant disease controlling effects of aryl phenyl ketone fungicide, and method for controlling plant diseases

Also Published As

Publication number Publication date
MEP10308A (en) 2010-06-10
MA25827A1 (fr) 2003-07-01
KR100760124B1 (ko) 2007-09-18
DE60130454T2 (de) 2008-06-05
RS50913B (sr) 2010-08-31
WO2002002527A1 (en) 2002-01-10
DE60130454D1 (de) 2007-10-25
CA2412282A1 (en) 2002-01-10
NL350079I1 (nl) 2017-10-12
CN100336807C (zh) 2007-09-12
ATE372984T1 (de) 2007-09-15
ES2296767T3 (es) 2008-05-01
FR15C0008I1 (hu) 2015-03-13
AR029289A1 (es) 2003-06-18
NL350079I2 (nl) 2018-01-09
PT1296952E (pt) 2007-10-03
TWI286548B (en) 2007-09-11
CN1440389A (zh) 2003-09-03
DK1296952T3 (da) 2008-03-10
PL360431A1 (en) 2004-09-06
KR20030016371A (ko) 2003-02-26
HU230070B1 (hu) 2015-06-29
AU2001269456B2 (en) 2006-08-31
LU93106I2 (en) 2016-08-16
BR0112199B1 (pt) 2013-09-03
AU6945601A (en) 2002-01-14
BR0112199A (pt) 2003-05-13
EG22882A (en) 2003-10-30
MY127330A (en) 2006-11-30
CY1107010T1 (el) 2012-09-26
US20030216444A1 (en) 2003-11-20
EP1296952B1 (en) 2007-09-12
YU101302A (sh) 2006-05-25
EP1296952A1 (en) 2003-04-02
HUP0400527A2 (hu) 2004-08-30
EP1296952B9 (en) 2008-01-09
CA2412282C (en) 2010-09-07
MXPA02012875A (es) 2004-07-30
FR15C0008I2 (fr) 2015-08-28
HUS1500038I1 (hu) 2018-07-30
IL153779A0 (en) 2003-07-31
PL209746B1 (pl) 2011-10-31
HUP0400527A3 (en) 2005-11-28

Similar Documents

Publication Publication Date Title
US6770662B2 (en) Benzoylpyridine derivative or its salt, fungicide containing it as an active ingredient, its production process and intermediate for producing it
AU2001269456A1 (en) Benzoylpyridine derivative or its salt, fungicide containing it as an active ingredient, its production process and intermediate for producing it
US20060089390A1 (en) 3-benzoyl-2,4,5-substituted pyridine derivatives or salts thereof and bactericides containing the same
AU2011201943B2 (en) Bactericide composition and method of controlling plant disease
US8420572B2 (en) Fungicidal composition containing carboxylic acid amide derivative
JP4608140B2 (ja) ベンゾイルピリジン誘導体またはその塩、それらを有効成分として含有する殺菌剤、それらの製造方法ならびにそれらを製造するための中間体
RU2255088C2 (ru) Производное бензоилпиридина или его соль, содержащий его в качестве активного ингредиента фунгицид, способы его получения и промежуточные соединения для его получения
AP1286A (en) Benzoylpyridine derivative or its salt, Fungicide containing it as an active ingredient, its production process and intermediate for producing it.
AU2012216657B2 (en) Bactericide composition and method of controlling plant disease
JP2004339208A (ja) フェニルヒドラジン誘導体又はその塩、それらの製造方法、並びにそれらを有効成分として含有する殺菌剤
JP2004168757A (ja) 3−ベンゾイル−2,4,5−置換ピリジン誘導体またはその塩及びそれらを含有する殺菌剤
JP2005002097A (ja) 置換ベンゼン誘導体又はその塩を有効成分として含有する殺菌剤
JPH11315069A (ja) ビニルスルホン誘導体またはその塩、それらの製造方法、それらの中間体およびそれらを有効成分として含有する有害生物防除剤

Legal Events

Date Code Title Description
AS Assignment

Owner name: ISHIHARA SANGYO KAISHA, LTD., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NISHIDE, HISAYA;OGAWA, MUNEKAZU;KOMINAMI, HIDEMASA;AND OTHERS;REEL/FRAME:013793/0494;SIGNING DATES FROM 20021203 TO 20021204

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12